miloxacin

Modify Date: 2025-08-21 19:40:54

miloxacin Structure
miloxacin structure
Common Name miloxacin
CAS Number 37065-29-5 Molecular Weight 263.203
Density 1.6±0.1 g/cm3 Boiling Point 460.9±55.0 °C at 760 mmHg
Molecular Formula C12H9NO6 Melting Point 264° (dec)
MSDS N/A Flash Point 232.5±31.5 °C

 Names

Name 5-methoxy-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.6±0.1 g/cm3
Boiling Point 460.9±55.0 °C at 760 mmHg
Melting Point 264° (dec)
Molecular Formula C12H9NO6
Molecular Weight 263.203
Flash Point 232.5±31.5 °C
Exact Mass 263.042999
PSA 86.99000
LogP 1.34
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.689
InChIKey ABQYZRZVRIPTPI-UHFFFAOYSA-N
SMILES COn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
JI5060000
CHEMICAL NAME :
1,3-Dioxolo(4,5-g)quinoline-7-carboxylic acid, 5,8-dihydro-5-methoxy-8-oxo-
CAS REGISTRY NUMBER :
37065-29-5
LAST UPDATED :
199612
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C12-H9-N-O6
MOLECULAR WEIGHT :
263.22
WISWESSER LINE NOTATION :
T C566 DO FO JN MV EHJ JO1 LVQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
36400 mg/kg/26W-I
TOXIC EFFECTS :
Liver - changes in liver weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Related to Chronic Data - changes in uterine weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
413 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1650 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3300 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
8100 mg/kg
SEX/DURATION :
female 17-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive - Effects on Newborn - physical

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Microorganism - not otherwise specified
DOSE/DURATION :
140 ug/L
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972- Volume(issue)/page/year: 17,763,1980

 Safety Information

HS Code 2934999090

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5,8-dihydro-5-methoxy-8-oxo-
miloxacin
Antibiotic AB 206
5-Methoxy-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
AB 206
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

miloxacin suppliers

miloxacin price